Experts warn against new celebrity-led trend for taking common medication to beat anxiety: ‘Raised risk of death’
Experts are warning people against taking the little blue pill celebrities promise will calm nervous jitters in all…
San Antonio clinics use magnetic fields to treat major depression
San Antonio residents who suffer from depression have historically had access to two clinical treatment options: psychotherapy and…
FDA cracks down on prescription drug ads but lacks staff
WASHINGTON – In an unprecedented move, federal regulators published about 100 warning letters sent to pharmaceutical companies and health…
Russia claims its cancer vaccine reduces tumors by 80 percent… announces it is safe and ‘ready to use’
Russian government officials have announced what could be a monumental achievement in the fight against colorectal cancer, though details…
Saol Therapeutics hit with CRL for rare genetic disease
The U.S. FDA issued a complete response letter (CRL) for the NDA to privately held Saol Therapeutics Inc.’s…
How a change in FDA guidance might revolutionise MASH drug development
Transformative new shifts have taken place in the last month in the metabolic dysfunction-associated steatohepatitis (MASH) therapy space,…
What To Know About The New Updated Covid Vaccines For 2025-2026
A medical workers holds a vial of the new Moderna child Covid-19 vaccine before filling syringes with it…
Hidden erectile dysfunction drug found in counterfeit supplement, FDA warns
A company behind a popular dietary supplement for men is alerting the public that a counterfeit of its…
Legal group sues FDA over puberty blocker records, citing alleged Biden-era cover-up
America First Legal (AFL) sued the Food and Drug Administration on Friday to obtain Biden-era records related to…
Medicines Reimagined – Repurposing Drugs For New Indications
In a group of health-related headlines, one says “Hope for new drug approach. getty As government-supported research in…
Ionis gets approval for preventing attacks in rare and genetic HAE
In Ionis Pharmaceuticals Inc.’s second U.S. FDA approval in under a year, the agency approved Dawnzera (donidalorsen) as…
FDA Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment for Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease
“Non-cystic fibrosis bronchiectasis deeply affects the lives of people living with this chronic lung condition, impacting both their…